Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.

Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA.

J Biol Chem. 1988 Nov 25;263(33):17755-62.

2.

Evolution and pathophysiology of the human natural anti-alpha-galactosyl IgG (anti-Gal) antibody.

Galili U.

Springer Semin Immunopathol. 1993;15(2-3):155-71. Review.

PMID:
7504839
3.

Xenotransplantation and ABO incompatible transplantation: the similarities they share.

Galili U.

Transfus Apher Sci. 2006 Aug;35(1):45-58. Epub 2006 Aug 14. Review.

PMID:
16905361
4.
5.
6.

Oligosaccharides and discordant xenotransplantation.

Cooper DK, Koren E, Oriol R.

Immunol Rev. 1994 Oct;141:31-58. Review.

PMID:
7868156
7.

Significance of the evolutionary α1,3-galactosyltransferase (GGTA1) gene inactivation in preventing extinction of apes and old world monkeys.

Galili U.

J Mol Evol. 2015 Jan;80(1):1-9. doi: 10.1007/s00239-014-9652-x. Epub 2014 Oct 15. Review.

PMID:
25315716
8.
9.

Anti-Gal: an abundant human natural antibody of multiple pathogeneses and clinical benefits.

Galili U.

Immunology. 2013 Sep;140(1):1-11. doi: 10.1111/imm.12110. Review.

10.

Cancer immunotherapy for pancreatic cancer utilizing α-gal epitope/natural anti-Gal antibody reaction.

Tanemura M, Miyoshi E, Nagano H, Eguchi H, Matsunami K, Taniyama K, Hatanaka N, Akamatsu H, Mori M, Doki Y.

World J Gastroenterol. 2015 Oct 28;21(40):11396-410. doi: 10.3748/wjg.v21.i40.11396. Review.

11.

Role of α-gal epitope/anti-Gal antibody reaction in immunotherapy and its clinical application in pancreatic cancer.

Tanemura M, Miyoshi E, Nagano H, Eguchi H, Taniyama K, Kamiike W, Mori M, Doki Y.

Cancer Sci. 2013 Mar;104(3):282-90. doi: 10.1111/cas.12084. Epub 2013 Feb 6. Review.

12.

Natural anti-carbohydrate antibodies contributing to evolutionary survival of primates in viral epidemics?

Galili U.

Glycobiology. 2016 Nov;26(11):1140-1150. doi: 10.1093/glycob/cww088. Epub 2016 Aug 27. Review.

PMID:
27567275
13.

[Past and present studies on ABO blood group system].

Takizawa H.

Nihon Hoigaku Zasshi. 1998 Oct;52(5):265-76. Review. Japanese.

PMID:
10077971
14.

Avoiding detrimental human immune response against Mammalian extracellular matrix implants.

Galili U.

Tissue Eng Part B Rev. 2015 Apr;21(2):231-41. doi: 10.1089/ten.TEB.2014.0392. Epub 2014 Nov 20. Review.

PMID:
25315097
15.

[Why humans and Catarrhini lack the Galalpha1-3Gal epitope, related to xenograft rejection?].

Suchanowska A, Czerwiński M.

Postepy Hig Med Dosw (Online). 2009 Jun 4;63:250-7. Review. Polish.

16.

Acceleration of wound healing by α-gal nanoparticles interacting with the natural anti-Gal antibody.

Galili U.

J Immunol Res. 2015;2015:589648. doi: 10.1155/2015/589648. Epub 2015 Apr 1. Review.

17.

The Galalpha1,3Galbeta1,4GlcNAc-R (alpha-Gal) epitope: a carbohydrate of unique evolution and clinical relevance.

Macher BA, Galili U.

Biochim Biophys Acta. 2008 Feb;1780(2):75-88. Epub 2007 Nov 22. Review.

18.

The natural anti-Gal antibody: evolution and autoimmunity in man.

Galili U.

Immunol Ser. 1991;55:355-73. Review. No abstract available.

PMID:
1720027
19.

Preparation of autologous leukemia and lymphoma vaccines expressing alpha-gal epitopes.

Galili U, Chen ZC, Manches O, Plumas J, Preisler H.

J Hematother Stem Cell Res. 2001 Aug;10(4):501-11. Review.

PMID:
11522233
20.

α-Gal Nanoparticles in Wound and Burn Healing Acceleration.

Galili U.

Adv Wound Care (New Rochelle). 2017 Mar 1;6(3):81-92. doi: 10.1089/wound.2016.0703. Review.

Supplemental Content

Support Center